Previous studies have found that PDIA3P1 is highly expressed in hepatocellular carcinoma and regulates nuclear factor kappa light chain enhancer of activated B cell signaling and chemotherapy resistance through PDIA3P1-miR-125/124-TRAF6 [33]. Here, TRAF6 is linked to hepatocellular carcinoma.